BUZZ-European pharma: top fallers on Stoxx 600 amid pricing pressure concern
** Hikma Pharmaceuticals (LSE: HIK.L - news) , Shire (Xetra: S7E.DE - news) , Qiagen , BB Biotech (LSE: 0JYO.L - news) fall 3-5 pct
** Track weakness overnight in US healthcare, dragged down by >5% drop in Mylan (Hamburg: 27249935.HM - news) as political pressure mounted on company after price increases for its EpiPen allergy treatment
** Democratic presidential candidate Hillary Clinton called for lower price on EpiPen (up >400% in the past decade)
** Hikma hits 2-mth low; extends losses from Wednesday when it posted 14 pct drop in H1 core operating profit
** European healthcare subsector currently -2.2 pct, worst performer of Pan European Stoxx
** Hikma is the worst performer on Stoxx 600, followed by Shire